
clinicaloptions.com
Jun 18, 2025, 07:42
Mikkael A. Sekeres: Top Line VERONA Results – No Advantage to AZA + VEN Compared to AZA Alone for HR-MDS
Mikkael A. Sekeres, Chief, Division of Hematology at Sylvester Comprehensive Cancer Center, shared on X:
“Wow – top line VERONA results are negative – no advantage to AZA + VEN compared to AZA alone for higher-risk MDS. AZA or DAC alone remain the standard for HR-MDS. So disappointing.”
More posts featuring Mikkael A. Sekeres.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 18, 2025, 07:40
Jun 18, 2025, 07:08